Presentation TCT 2012 Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy Presenter: Renu Virmani October 23, 2012
Presentation TCT 2012 TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions Presenter: Dierk Scheinert October 23, 2012
Presentation TCT 2012 Management of the Device Patient for the Non-EP MD Presenter: Ralph Verdino October 23, 2012
Presentation TCT 2012 TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease Presenter: Lamin King October 23, 2012
Presentation TCT 2012 What Will We Learn from the EXCEL Trial that We Do Not Already Know? Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction Presenter: Markus Schlaich October 23, 2012
Presentation TCT 2012 Quality-of-Life and Cost-Effectiveness After LAA Closure Presenter: Vivek Reddy October 23, 2012
Presentation TCT 2012 Case Presentation: A Complicated LARIAT Case Presenter: Randall Lee October 23, 2012
Presentation TCT 2012 Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores? Presenter: Roxana Mehran October 23, 2012
Presentation TCT 2012 Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology Presenter: Robert Cottone October 23, 2012